72 Participants Needed

MOV'D + Fitbit Monitoring for Sedentary Lifestyle

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial tests the MOV'D program, which sends short exercise videos and tips via social media to help people take breaks from sitting at work. It targets those who sit a lot and don't get enough exercise, aiming to improve heart health by encouraging regular exercise breaks.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Fitbit Self-Monitoring, MOV'D (Move Often eVery Day) for sedentary lifestyle?

Research shows that wearable devices like Fitbit can help increase physical activity in people with chronic health conditions and cancer survivors, suggesting they may also be effective for reducing sedentary behavior.12345

Is the MOV'D + Fitbit Monitoring treatment safe for humans?

The research does not provide specific safety data for MOV'D + Fitbit Monitoring, but using a Fitbit for tracking physical activity is generally considered safe for most people.26789

How is the MOV'D treatment with Fitbit monitoring different from other treatments for a sedentary lifestyle?

The MOV'D treatment is unique because it combines a behavioral approach to encourage regular movement with the use of Fitbit devices to monitor and motivate activity levels, providing real-time feedback and tracking that can help individuals become more aware of their sedentary habits.410111213

Research Team

MA

Marily A. Oppezzo, PhD MS, RDN, DipACLM

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for full-time employees who spend over half their work time sitting, can safely exercise (as determined by the PAR-Q), read English, and have a smartphone with internet. It's not suitable for those who don't meet these criteria.

Inclusion Criteria

English literacy
Safe to exercise, assessed by the Physical Activity Readiness Questionnaire (PAR-Q)
Have smartphone with internet capabilities
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to either the MOV'D intervention or a Fitbit-only control for one month

4 weeks
Remote participation

Follow-up

Participants are monitored for changes in MVPA minutes and active workday hours

4 weeks
Remote monitoring

Treatment Details

Interventions

  • Fitbit Self-Monitoring
  • MOV'D (Move Often eVery Day)
Trial OverviewThe MOV'D program aims to reduce long sitting periods at work using 'exercise snacks'—short bursts of activity—and behavior change techniques shared via social media support groups. Participants will also self-monitor with Fitbit devices.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: MOV'D plus Fitbit Self-MonitoringExperimental Treatment2 Interventions
Treatment participants will be sent a Fitbit and study-provided account, and assigned to a private, study-created Twitter support group of 10 participants. Within the private group of 10, each participant is also further paired with a peer to be that person's peer coach, setting weekly exercise snack goals and practicing behavior change techniques.
Group II: Fitbit-Only Self-MonitoringActive Control1 Intervention
Control participants will be sent a Fitbit and study-provided account and will self-monitor physical activity for the duration of the study period (2 months).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Findings from Research

A systematic review of 14 studies found a weak-to-moderate positive association between physical activity measured by wearable activity monitors (WAMs) and performance status (PS) in cancer patients, indicating that more activity may correlate with better performance.
Conversely, there was a weak-to-moderate negative association between sedentary behavior (SB) metrics from WAMs and PS, suggesting that less sedentary time could be linked to improved performance, but WAM data should not replace physician assessments.
The association between wearable activity monitor metrics and performance status in oncology: a systematic review.Kos, M., Pijnappel, EN., Buffart, LM., et al.[2022]
Cancer survivors using wearable activity trackers, like Fitbits, have shown an increase in physical activity, which is important for reducing negative effects from cancer treatments and improving overall health outcomes.
The review identified 13 relevant studies, including 8 randomized controlled trials, indicating a need for further research to better understand how these devices can effectively promote physical activity and weight management in cancer survivors.
Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies.Coughlin, SS., Caplan, LS., Stone, R.[2020]

References

Wearable Technology and Physical Activity Behavior Change in Adults With Chronic Cardiometabolic Disease: A Systematic Review and Meta-Analysis. [2020]
Validity and Reliability of Fitbit Flex for Step Count, Moderate to Vigorous Physical Activity and Activity Energy Expenditure. [2022]
The association between wearable activity monitor metrics and performance status in oncology: a systematic review. [2022]
The Validity of Consumer-Level Activity Monitors in Healthy Older Adults in Free-Living Conditions. [2019]
Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies. [2020]
Feedback from physical activity monitors is not compatible with current recommendations: A recalibration study. [2022]
Validity and reliability of Fitbit activity monitors compared to ActiGraph GT3X+ with female adults in a free-living environment. [2022]
Wearable accelerometer-derived physical activity and incident disease. [2023]
U.S. population profile of time-stamped accelerometer outputs: impact of wear time. [2019]
A Comparison of Sedentary Behavior as Measured by the Fitbit and ActivPAL in College Students. [2021]
Comparing Monitoring Results of Two Motion Trackers for Geriatric Patients. [2020]
12.United Statespubmed.ncbi.nlm.nih.gov
Comprehensive comparison of Apple Watch and Fitbit monitors in a free-living setting. [2021]
How well does a commercially available wearable device measure sleep in young athletes? [2019]